| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/24/2011 | CA2323072C Gfr.alpha.3 and its uses |
| 05/19/2011 | WO2011059021A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 05/19/2011 | WO2011058579A1 Pharmaceutical combination of prostaglandin compound and nsaid for the treatment of glaucoma and ocular hypertension |
| 05/19/2011 | WO2011058113A1 Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors |
| 05/19/2011 | WO2011058110A1 Quinoline and quinoxaline derivatives as kinase inhibitors |
| 05/19/2011 | WO2011057580A1 Organic dicarboxylic acids, salts and preparation method thereof |
| 05/19/2011 | WO2011057382A1 Spirocyclic piperidine derivatives useful as renin inhibitors |
| 05/19/2011 | WO2011006079A3 Ophthalmic formulations of reversed liquid crystalline phase materials and methods of using |
| 05/19/2011 | US20110118825 Anti-angiogenic compositions and methods of use |
| 05/19/2011 | US20110118470 Nitrogen-containing aromatic derivatives |
| 05/19/2011 | US20110118352 Oat extracts: refining, compositions and methods of use |
| 05/19/2011 | US20110118349 Use of prostaglandins f2alpha and analogues for the healing of corneal and conjunctival lesions |
| 05/19/2011 | US20110118348 Methods of stabilizing latanoprost in an aqueous solution |
| 05/19/2011 | US20110118275 OXAZOLO[4,5-c]PYRIDINE SUBSTITUTED PYRAZINE |
| 05/19/2011 | US20110118273 Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds |
| 05/19/2011 | US20110118265 Use of anti-bacterial agents for the treatment of epithelial-related conditions |
| 05/19/2011 | US20110118260 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy group |
| 05/19/2011 | US20110118223 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 05/19/2011 | US20110118211 Novel glucokinase activators and methods of using same |
| 05/19/2011 | US20110118186 Synthetic peptide amides and dimeric forms thereof |
| 05/19/2011 | US20110118174 Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 05/19/2011 | US20110117189 Ophthalmic compositions for treating pathologies of the posterior segment of the eye |
| 05/19/2011 | US20110117186 Intravenous infusion of curcumin and a calcium channel blocker |
| 05/19/2011 | US20110117184 Compositions for mucosal delivery of agents |
| 05/19/2011 | US20110117172 Cross-linked polymer matrix, in particular for administering active substances |
| 05/19/2011 | US20110117102 Therapeutic uses of inhibitors of RTP801 |
| 05/19/2011 | US20110117084 Vandetanib derivatives |
| 05/19/2011 | US20110117063 Methods For Producing Enriched Populations of Human Retinal Pigment Epithelium Cells For Treatment of Retinal Degeneration |
| 05/19/2011 | US20110117062 Methods For Producing Enriched Populations of Human Retinal Pigment Epithelium Cells |
| 05/19/2011 | US20110117058 Method of treating genetic disorders |
| 05/19/2011 | US20110117053 Method of modulating fibroblast accumulation or collagen deposition |
| 05/19/2011 | US20110117029 Water-soluble anionic bacteriochlorophyll derivatives and their uses |
| 05/19/2011 | US20110117021 Fully human anti-vap-1 monoclonal antibodies |
| 05/19/2011 | CA2780611A1 Pharmaceutical combination of prostaglandin compound and nsaid for the treatment of glaucoma and ocular hypertension |
| 05/19/2011 | CA2780160A1 Methods and compositions for rapid treatment of otitis externa |
| 05/19/2011 | CA2778229A1 Methods for maintaining eye health and ameliorating ophthalmic maladies in canines |
| 05/19/2011 | CA2778175A1 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 05/18/2011 | EP2322601A1 Method of collecting placental stem cells |
| 05/18/2011 | EP2322549A1 Connective tissue growth factor antibodies |
| 05/18/2011 | EP2322219A2 Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease |
| 05/18/2011 | EP2322183A1 Use of prodrugs for ocular intravitreous administration |
| 05/18/2011 | EP2322174A2 Combined use of valsartan and calcium channel blockers for therapeutic purposes |
| 05/18/2011 | EP2321333A1 New no-releasing steroids for the treatment of retina and macula lutea diseases |
| 05/18/2011 | EP2321304A2 Therapeutic beta-lactams |
| 05/18/2011 | EP2320937A2 Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa |
| 05/18/2011 | EP2320912A1 Treatment of retinal degeneration |
| 05/18/2011 | EP2320911A1 Vasoconstriction compositions and methods of use |
| 05/18/2011 | EP2320904A2 Aminopyrimidine inhibitors of histamine receptors for the treatment of disease |
| 05/18/2011 | CN1527704B Compositions and method of administering tubulin binding agents for the treatment of ocular diseases |
| 05/18/2011 | CN1377415B 疫苗组合物 Vaccine compositions |
| 05/18/2011 | CN102066419A Humanized anti-factor D antibodies and uses thereof |
| 05/18/2011 | CN102066402A Peptide derivative and composition for promoting tear secretion comprising the same |
| 05/18/2011 | CN102065869A Antiallergic marine biopolymers |
| 05/18/2011 | CN102060842A 3-(substituted xylylenimine-2-yl)-2,6-piperidine diketone polymorph and medical composition |
| 05/18/2011 | CN102060809A Rhein derivatives and preparation and application thereof |
| 05/18/2011 | CN102060732A 5-amino-4-hydroxy-N-aryl azelamide derivatives as well as preparation methods and medical applications thereof |
| 05/18/2011 | CN102058845A Medicinal composition for treating macular degeneration |
| 05/18/2011 | CN102058749A Chinese medicinal composition for treating cataract |
| 05/18/2011 | CN102058621A Artificial bear bile |
| 05/18/2011 | CN102058579A Application of dehydrocostuslactone to preparing drug for inhibiting angiogenesis |
| 05/18/2011 | CN102058570A Application of carnosic acid in preparing medicament for suppressing angiogenesis |
| 05/18/2011 | CN102058567A Application of 3',4-dyhydroxyl-3,5'-dimethoxybibenzyl in preparing medicaments for treating cataract |
| 05/18/2011 | CN102058547A Freeze-dried preparation |
| 05/18/2011 | CN102058540A Azithromycin sustained-release microsphere and dry suspension, preparation method and application thereof |
| 05/18/2011 | CN102058294A Medicinal pillow for preventing paediatric otitis media and preparation method thereof |
| 05/18/2011 | CN101780034B Cefathiamidine suspension and novel application thereof |
| 05/18/2011 | CN101669909B Biological adhesive liposome preparation for eyes and preparation method thereof |
| 05/18/2011 | CN101366881B Traditional Chinese medicine for treating acute infectious conjunctivitis |
| 05/18/2011 | CN101352435B Use of lipoamide for preventing and treating age related macular degeneration |
| 05/17/2011 | US7943757 RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA) |
| 05/17/2011 | US7943643 Aryl substituted pyridines and the use thereof |
| 05/17/2011 | US7943635 Farnesyl-protein transferase inhibitors |
| 05/17/2011 | US7943627 2,4-diaminopyrimidine derivatives |
| 05/17/2011 | US7943616 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders |
| 05/17/2011 | US7943596 Pharmaceutical composition for dry eye, which remains on the cornea and exhibits a humectant effect for a longer period |
| 05/17/2011 | US7943571 Modified proteins, designer toxins, and methods of making thereof |
| 05/17/2011 | US7943332 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 05/17/2011 | CA2487840C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and their therapeutic application |
| 05/17/2011 | CA2463552C Treatment of neurodegenerative diseases and cancer of the brain |
| 05/17/2011 | CA2451521C Use of poly-glu, tyr for neuroprotective therapy |
| 05/17/2011 | CA2414484C Muscle-strengthening drugs and anti-inflammatory drugs |
| 05/17/2011 | CA2413945C Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/17/2011 | CA2401385C Protein matrix materials, devices and methods of making and using thereof |
| 05/12/2011 | WO2011057183A1 Nutritional supplements for relief of dry eye |
| 05/12/2011 | WO2011057108A1 Ophthalmic formulations containing substituted gamma lactams and methods for use thereof |
| 05/12/2011 | WO2011056502A1 Bone morphogenetic protein receptor type ii compositions and methods of use |
| 05/12/2011 | WO2011056497A1 Activin receptor type iib compositions and methods of use |
| 05/12/2011 | WO2011056222A1 Methods of treating disorders associated with protein aggregation |
| 05/12/2011 | WO2011055561A1 Protein crosslinking inhibitor and use thereof |
| 05/12/2011 | WO2011055550A1 Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent |
| 05/12/2011 | WO2011055377A1 A novel process for the preparation of prostaglandins and intermediates thereof |
| 05/12/2011 | WO2011054993A1 Peptides for the treatment of ocular hypertension and/or glaucoma |
| 05/12/2011 | US20110112193 Bis-aryl compounds for use as medicaments |
| 05/12/2011 | US20110112187 Use Of Tranilast And Derivatives Thereof For The Therapy Of Neurological Conditions |
| 05/12/2011 | US20110112168 Novel sirna structures |
| 05/12/2011 | US20110112145 Salts Of Methyl 2-((R))-(3-Chlorophenyl)((R)-1-((S)-2-(Methylamino)-3((R)-tetrahydro-2H-Pyran-3-YL)Propylcarbamoyl)Piperidin-3-YL)Methoxy)Ethylcarbamate |
| 05/12/2011 | US20110112142 Novel estrogen receptor ligands |
| 05/12/2011 | US20110112102 Method of treating cancer using a neuropeptide y 5r (np y5r) antagonist |
| 05/12/2011 | US20110112101 Treatment for ocular-related disorders |
| 05/12/2011 | US20110112082 Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |